Carol Stuckley
Director/Board Member en CENTESSA PHARMACEUTICALS PLC .
Fortuna: - $ al 29/02/2024
Perfil
Carol Stuckley is on the board of Transgene SA and Centessa Pharmaceuticals Plc.
Ms. Stuckley previously occupied the position of Vice President-Finance & Assistant Treasurer at Pfizer Inc., Chief Financial Officer & Senior VP-Finance at Galderma Laboratories LP, Chief Financial Officer & Senior Vice President of Healthcare Payment Specialists LLC and President & Director at Financial Executives International of Fort Worth Chapter.
Carol Stuckley received an MBA and a graduate degree from Fox School of Business and an undergraduate degree from the University of Delaware.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
22/06/2023 | 0 ( -.--% ) | - $ | 29/02/2024 |
Cargos activos de Carol Stuckley
Empresas | Cargo | Inicio |
---|---|---|
CENTESSA PHARMACEUTICALS PLC | Director/Board Member | 17/05/2021 |
TRANSGENE | Director/Board Member | 05/05/2023 |
Antiguos cargos conocidos de Carol Stuckley.
Empresas | Cargo | Fin |
---|---|---|
EPIZYME, INC. | Director/Board Member | 12/08/2022 |
IPSEN | Director/Board Member | 01/08/2021 |
Healthcare Payment Specialists LLC
Healthcare Payment Specialists LLC Miscellaneous Commercial ServicesCommercial Services Healthcare Payment Specialists LLC provides payment and reimbursement solutions. The firm’s solutions include Stingary SAAS, Medicare bad debt, Medicare disproportionate share, Shadow billing compliance, Transfer DRG, Volume decrease adjustment and Complex drug review. It also offers consulting services. The company was founded in 2002 by Peter Jarvis and is headquartered in Fort Worth, TX. | Director of Finance/CFO | 01/07/2019 |
Galderma Laboratories LP
Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Galderma Laboratories LP develops and markets dermatology and prescription products. It also offers treatments for skin conditions such as acne, rosacea, atopic dermatitis, soriasis, melasma and sunspots. Galderma Laboratories was founded in 1961 and is headquartered in Fort Worth, TX. | Director of Finance/CFO | 01/01/2013 |
Financial Executives International of Fort Worth Chapter | President | - |
Formación de Carol Stuckley.
University of Delaware | Undergraduate Degree |
Fox School of Business | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
PFIZER, INC. | Health Technology |
TRANSGENE | Health Technology |
IPSEN | Health Technology |
CENTESSA PHARMACEUTICALS PLC | Health Technology |
Empresas privadas | 4 |
---|---|
Galderma Laboratories LP
Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Galderma Laboratories LP develops and markets dermatology and prescription products. It also offers treatments for skin conditions such as acne, rosacea, atopic dermatitis, soriasis, melasma and sunspots. Galderma Laboratories was founded in 1961 and is headquartered in Fort Worth, TX. | Health Technology |
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Healthcare Payment Specialists LLC
Healthcare Payment Specialists LLC Miscellaneous Commercial ServicesCommercial Services Healthcare Payment Specialists LLC provides payment and reimbursement solutions. The firm’s solutions include Stingary SAAS, Medicare bad debt, Medicare disproportionate share, Shadow billing compliance, Transfer DRG, Volume decrease adjustment and Complex drug review. It also offers consulting services. The company was founded in 2002 by Peter Jarvis and is headquartered in Fort Worth, TX. | Commercial Services |
Financial Executives International of Fort Worth Chapter |